Axsome Therapeutics reported revenue of $218.38M and net income of -$51.31M for the quarter ended Jun 2026, up 45.5% year over year. This income statement covers 46 quarters of results from Mar 2015 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Mar2015 | Jun2015 | Sep2015 | Dec2015 | Mar2016 | Jun2016 | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | ||||||||||||||||||||||||||||||||||||||||||||||
| Revenue | 8.82M | 16.85M | 24.37M | 94.58M | 46.70M | 57.79M | 71.53M | 75.00M | 87.17M | 104.76M | 0.50M | 121.46M | 150.04M | 170.99M | 196.00M | 191.20M | 218.38M | |||||||||||||||||||||||||||||
| Cost of RevenueCost of Rev | 0.98M | 1.92M | 2.29M | 7.56M | 4.60M | 6.53M | 7.38M | 6.30M | 8.05M | 8.44M | 10.51M | 9.79M | 13.45M | 11.91M | 12.33M | 14.72M | 13.56M | |||||||||||||||||||||||||||||
| Gross Profit | 7.84M | 14.92M | 22.08M | 87.02M | 42.10M | 51.26M | 64.15M | 68.70M | 79.11M | 96.33M | -10.01M | 111.67M | 136.59M | 159.08M | 183.67M | 176.48M | 204.81M | |||||||||||||||||||||||||||||
| Operating items | ||||||||||||||||||||||||||||||||||||||||||||||
| Amortization - Intangibles | 0.93M | 1.61M | 1.61M | 1.60M | 1.59M | 1.61M | 1.61M | 1.59M | 1.59M | 1.61M | 1.61M | 1.57M | 1.59M | 1.61M | 1.61M | 1.57M | 1.59M | |||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 13.18M | 13.78M | 12.59M | 15.79M | 14.88M | 14.69M | 17.79M | 20.58M | 28.77M | 30.80M | 36.83M | 49.85M | 45.39M | 55.01M | 44.78M | 49.54M | 40.16M | 2.60M | 52.68M | 46.23M | ||||||||||||||||||||||||||
| Selling, General & AdministrativeSG&A | 20.23M | 18.83M | 25.70M | 31.16M | 40.89M | 61.50M | 74.19M | 78.94M | 83.19M | 86.81M | 98.97M | 103.55M | 95.56M | 113.27M | 120.79M | 130.28M | 150.24M | 169.30M | 185.00M | 208.14M | ||||||||||||||||||||||||||
| Other Operating ExpensesOther Opex | 1.05M | 3.49M | 8.10M | 8.97M | 12.24M | 7.96M | 52.19M | 6.47M | 11.80M | 26.43M | 23.11M | 12.87M | 6.93M | 26.70M | 51.06M | 16.89M | 13.66M | |||||||||||||||||||||||||||||
| Operating ExpensesOpex | 33.41M | 32.61M | 38.29M | 48.00M | 59.26M | 84.29M | 100.95M | 111.76M | 119.91M | 169.80M | 142.27M | 165.21M | 167.39M | 191.38M | 178.44M | 186.76M | 217.10M | 222.96M | 254.56M | 268.02M | ||||||||||||||||||||||||||
| Operating IncomeOp. Inc | -33.41M | -32.61M | -38.29M | -39.18M | -42.41M | -59.92M | -6.37M | -65.06M | -62.12M | -98.27M | -67.28M | -78.05M | -62.62M | -72.62M | -56.98M | -36.71M | -46.11M | -26.96M | -63.36M | -49.65M | ||||||||||||||||||||||||||
| EBIT | -33.41M | -32.61M | -38.29M | -39.18M | -42.41M | -59.92M | -6.37M | -65.06M | -62.12M | -98.27M | -67.28M | -78.05M | -62.62M | -72.62M | -56.98M | -36.71M | -46.11M | -26.96M | -63.36M | -49.65M | ||||||||||||||||||||||||||
| Non-operating items | ||||||||||||||||||||||||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | -1.48M | -1.37M | -1.34M | -2.26M | -2.41M | -1.32M | -2.26M | -2.73M | -0.76M | -0.70M | -1.08M | -1.30M | -1.98M | -2.21M | -2.43M | -1.83M | -1.12M | -1.17M | -1.19M | -1.54M | ||||||||||||||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | -10.38M | |||||||||||||||||||||||||||||||||||||||||||||
| Net income details | ||||||||||||||||||||||||||||||||||||||||||||||
| EBT | -34.88M | -33.98M | -39.63M | -41.44M | -44.82M | -61.24M | -8.64M | -67.79M | -62.88M | -98.98M | -68.36M | -79.34M | -64.60M | -74.83M | -59.41M | -48.93M | -47.23M | -28.13M | -64.54M | -51.19M | ||||||||||||||||||||||||||
| Tax ProvisionsTaxes | 2.60M | -0.62M | -0.70M | -0.34M | 0.09M | -1.00M | -37.48M | 0.13M | ||||||||||||||||||||||||||||||||||||||
| Profit After TaxPAT | -34.88M | -33.98M | -39.63M | -41.44M | -44.82M | -61.24M | -11.22M | -67.17M | -62.20M | -98.65M | -68.36M | -79.34M | -64.60M | -74.91M | -59.41M | -47.97M | -47.23M | -28.56M | -64.54M | -51.31M | ||||||||||||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -34.88M | -33.98M | -39.63M | -41.44M | -44.82M | -61.24M | -11.24M | -67.17M | -62.18M | -98.64M | -68.36M | -79.34M | -64.60M | -74.91M | -59.41M | -47.93M | -47.23M | 9.35M | -64.54M | -51.31M | ||||||||||||||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -34.88M | -33.98M | -39.63M | -41.44M | -44.82M | -61.24M | -11.24M | -67.17M | -62.18M | -98.64M | -68.36M | -79.34M | -64.60M | -74.91M | -59.41M | -47.93M | -47.23M | 9.35M | -64.54M | -51.31M | ||||||||||||||||||||||||||
| Income towards Parent CompanyParent Net Inc | -34.88M | -33.98M | -39.63M | -41.44M | -44.82M | -61.24M | -11.24M | -67.17M | -62.18M | -98.64M | -68.36M | -79.34M | -64.60M | -74.91M | -59.41M | -47.93M | -47.23M | 9.35M | -64.54M | -51.31M | ||||||||||||||||||||||||||
| Net Income towards Common StockholdersNet Income | -34.88M | -33.98M | -39.63M | -41.44M | -44.82M | -61.24M | -11.24M | -67.17M | -62.18M | -98.64M | -68.36M | -79.34M | -64.60M | -74.91M | -59.41M | -47.93M | -47.23M | 9.35M | -64.54M | -51.31M | ||||||||||||||||||||||||||
| Additional items | ||||||||||||||||||||||||||||||||||||||||||||||
| EPS (Basic) | -0.93 | -0.90 | -1.03 | -1.06 | -1.07 | -1.51 | -0.26 | -1.54 | -1.32 | -2.17 | -1.44 | -1.67 | -1.34 | -1.56 | -1.22 | -0.97 | -0.94 | 0.19 | -1.26 | -0.99 | ||||||||||||||||||||||||||
| EPS (Diluted) | -0.93 | -0.90 | -1.03 | -1.06 | -1.07 | -1.51 | -0.26 | -1.54 | -1.32 | -2.17 | -1.44 | -1.67 | -1.34 | -1.56 | -1.22 | -0.97 | -0.94 | 0.19 | -1.26 | -0.99 | ||||||||||||||||||||||||||
| Shares Outstanding | 37.68M | 37.62M | 38.32M | 39.08M | 41.70M | 40.66M | 43.52M | 43.67M | 47.12M | 45.43M | 47.39M | 47.57M | 48.14M | 47.91M | 48.87M | 49.44M | 50.02M | 49.75M | 51.20M | 51.80M | ||||||||||||||||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 37.68M | 37.62M | 38.32M | 39.08M | 41.70M | 40.66M | 43.52M | 43.67M | 47.12M | 45.43M | 47.39M | 47.57M | 48.14M | 47.91M | 48.87M | 49.44M | 50.02M | 49.75M | 51.20M | 51.80M | ||||||||||||||||||||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 37.69M | 37.82M | 38.88M | 39.91M | 43.43M | 43.50M | 43.55M | 46.73M | 47.32M | 47.35M | 47.46M | 47.80M | 48.44M | 48.67M | 49.22M | 49.82M | 50.31M | 50.88M | 51.42M | 52.30M | ||||||||||||||||||||||||||
| EBITDA | -33.41M | -32.61M | -38.29M | -39.18M | -42.41M | -59.92M | -6.37M | -65.06M | -62.12M | -98.27M | -67.28M | -78.05M | -62.62M | -72.62M | -56.98M | -36.71M | -46.11M | -26.96M | -63.36M | -49.65M | ||||||||||||||||||||||||||
| Tax Rate | -30.10% | 0.91% | 1.11% | 0.34% | -0.11% | 2.04% | 133.24% | -0.25% |